(NASDAQ: AZTA) Azenta's forecast annual revenue growth rate of 5.98% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 11.52%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 66.01%.
Azenta's revenue in 2026 is $594,953,000.On average, 10 Wall Street analysts forecast AZTA's revenue for 2026 to be $29,061,600,492, with the lowest AZTA revenue forecast at $27,616,650,327, and the highest AZTA revenue forecast at $30,238,933,173. On average, 10 Wall Street analysts forecast AZTA's revenue for 2027 to be $30,637,365,399, with the lowest AZTA revenue forecast at $29,124,704,787, and the highest AZTA revenue forecast at $32,017,368,808.
In 2028, AZTA is forecast to generate $32,649,332,986 in revenue, with the lowest revenue forecast at $30,167,077,188 and the highest revenue forecast at $34,338,869,870.